Gender pay gap report 2020

At GenesisCare, we’re the UK’s leading private cancer care provider, and each year we provide world-class cancer treatment to thousands of patients at our specialist centres. Providing Radiotherapy, Medical Oncology, Theranostics, Cancer Diagnosis, and Benign treatment services, GenesisCare employ a network of experienced clinical teams across the UK. We’re renowned for the excellent care we provide and we’re proud to be rated in the top 1% of healthcare providers worldwide for patient satisfaction.

Under the statutory requirements we are required to report gender pay gap figures for our main employing entity – Genesis Cancer Care UK Limited.  The data illustrates our gender pay gap as at 5th April 2020.  The gender pay gap is the difference between the average (mean or median) hourly earnings of men and women across the organisation and is expressed as a percentage figure.    Genesis Cancer Care UK Limited has a workforce demographic that is 76.9% female.

The median represents the mid-point of the range of data.

The mean represents the sum of all data, divided by the total number of employees.

Gender Pay Gap reporting is distinct from “equal pay” which is about paying men and women differently for performing the same or similar work.

GenesisCare have 412 relevant employees. This group is used to calculate the gender bonus gap and bonuses paid figures. For the gender pay gap figures, a total of 17 men and women were excluded because they received less than normal pay during the month of April 2020. This leaves a count of 395 full-pay relevant employees of which 304 (76.9%) are women and 91 (23.1%) are men.

This table shows the mean and median percentage differences between the hourly rates paid to each gender.

This table shows the percentage of men and women that received a bonus in the twelve months preceding the snapshot date. Our bonus schemes are gender-neutral by design and based on the level of responsibility held by the individual, company and individual performance metrics.

This table shows the mean and median percentage differences between the hourly rates paid to each gender.

At GenesisCare our renumeration packages are based upon skills and experience and are reflective of the level of responsibility held.  Our annual pay review processes are applied fairly to all employees across the organisation and pay awards are reflective of both personal performance and the prevailing market conditions.

Within Genesis Cancer Care UK Limited our female employees span the breadth of the organisation, however, as with many organisations, we have a higher proportion of women than men in lower paid roles.  Whilst for our upper-mid pay band we see a distribution of employees that is representative of the organisation gender make-up, we see an over-representation of women by 17% in the lower band of the organisation when compared to our overall distribution of employees.  This over-representation of women in the lower band is contributed to in the gender diversity of our clinical administration teams who are predominately female.  This is contrasted to an over-representation of men at the upper band of the organisation of 18.7% when compared to our overall distribution of employees.  This contrast is contributed to by the employment of leading consultant oncologists to ensure that we are able to provide the best possible patient care to individuals experiencing a cancer diagnosis and treatment pathway.  As at 5th April 2020, these consultants were predominately male.

In April 2020, 16 employees were furloughed under the Government Coronavirus Retention Scheme.  Of these employees, 9 employees (56.25%) were topped up to full pay by GenesisCare from the 80% Government funding to maintain their current earnings.  For the remaining 7 employees’ salaries who were furloughed, their salaries were paid at between 80% – 90% of earnings, with a guaranteed minimum £25,000 per annum salary.

In 2020, we also undertook a full benefit review for all employees which led to improved maternity pay provisions, sick pay provisions and increased pension contributions being implemented from 1st July 2020.

I confirm that the information published here is accurate:

Neil Budden

Finance Director

Genesis Cancer Care UK Limited